Neurotrope Inc.

Neurotrope Inc.
Stock Exchange Other OTC
EPS
$1.48
Market Cap
$96.84 M
Shares Outstanding
12.92 M
Public Float
4.99 M

Profile

Address
205 East 42nd Street
New York New York 10017
United States
Employees -
Website http://www.neurotropebioscience.com
Updated 07/08/2019
Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. It operates through the following geographical segments: US; European Union; Japan; and China and India. It focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease.

Financials

View All

Joshua N. Silverman
Chairman
Charles S. Ryan
Chief Executive Officer & Director